Typed states for the displayed outbound observations.
Source: paper_references, paper_reference_links, observed 2026-08-14T12:16:37.765468Z
Paper Citation Record · LEDGER
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance
As of 16 August 2026, this Paper Citation Record lists 33 of 33 outbound references and 0 inbound Pith citation observations for arXiv:1908.07751.
A citation records a reference. It does not transfer a finding from one paper to another.
Coverage vector
One-hop event checks from named stored sources.
Source: scholarly_work_events, retraction_status_cache, observed 2026-08-16T06:30:59.297886+00:00
Pith citing papers itemized under the disclosed page cap.
Source: paper_references, paper_reference_links
A source-named dated measurement, never combined with another source.
Source: cited_works
Reference resolution
33 of 33 outbound references displayed
- verified exact0
- verified fuzzy26
- unresolved7
- parse uncertain0
- malformed identifier0
- metadata mismatch0
External citation measurements
No source-named external measurement is stored.
Outbound references
Observation ebf7d88e-9b0a-4715-be22-31c3c7889b83 · outbound
This paper cites The ASA’s statement on p-values: Context, process, and purpose.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance The ASA’s statement on p-values: Context, process, and purpose
Reference 1
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.159250Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 94783df2-70a4-4bf9-a6ee-aac7bdcfe889 · outbound
This paper cites One-sample multiple testing procedure for phase II clinical trials.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance One-sample multiple testing procedure for phase II clinical trials
Reference 2
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.147475Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 2ef04326-5450-44d9-97ce-92b91e3b0871 · outbound
This paper cites Calibrated phase II clinical trials in oncology.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Calibrated phase II clinical trials in oncology
Reference 3
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.136236Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 5b019c17-e9b8-4ee9-8bbc-b68633ae2049 · outbound
This paper cites Optimal two-stage designs for phase II clinical trials.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Optimal two-stage designs for phase II clinical trials
Reference 4
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.125974Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 2e4473eb-42d9-432a-811f-c06a7010bc93 · outbound
This paper cites Optimal two-stage screening designs for survival comparisons.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Optimal two-stage screening designs for survival comparisons
Reference 5
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.115396Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 2822e411-f08a-45ef-a4f1-c79996fb0c7f · outbound
This paper cites A class of phase II designs with three possible outcomes.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance A class of phase II designs with three possible outcomes
Reference 6
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.105193Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation ba6bc467-db56-4da4-becc-0cb491eb2c5a · outbound
This paper cites Selection designs for pilot studies based on survival.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Selection designs for pilot studies based on survival
Reference 7
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.092734Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation d692cd6a-6e4b-4826-8b89-0683aa22bba8 · outbound
This paper cites False positive rates of randomized phase II designs.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance False positive rates of randomized phase II designs
Reference 8
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.081430Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 9f97fd36-db62-47ec-bd55-0ae9e5fff578 · outbound
This paper cites A three-outcome design for phase II clinical trials.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance A three-outcome design for phase II clinical trials
Reference 9
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.071601Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation f69bcf1e-c0d5-4145-85e5-7405c5c29a27 · outbound
This paper cites Clinical trial designs for cytostatic agents: Are new approaches needed? Journal of Clinical Oncology 2001; 19(1): 265–272.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Clinical trial designs for cytostatic agents: Are new approaches needed? Journal of Clinical Oncology 2001; 19(1): 265–272
Reference 10
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.061169Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation c841bed1-08e3-4f73-968d-9af368dc1417 · outbound
This paper cites Design issues of randomized phase ii trials and a proposal for phase II screening trials.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Design issues of randomized phase ii trials and a proposal for phase II screening trials
Reference 11
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.048383Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 09b6d6c4-3f63-4a29-8ad9-d0dfafebcc36 · outbound
This paper cites Clinical trial designs for the early clinical development of therapeutic cancer vaccines.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Clinical trial designs for the early clinical development of therapeutic cancer vaccines
Reference 12
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.037361Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 4144b912-39ae-4cc3-9a62-47c2f14dea94 · outbound
This paper cites An optimal stratified Simon two-stage design.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance An optimal stratified Simon two-stage design
Reference 13
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.027373Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 54418981-0e46-4b1b-b5e7-f746d1f61637 · outbound
This paper cites Proof of concept: a PhRMA position paper with recommendations for best practice.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Proof of concept: a PhRMA position paper with recommendations for best practice
Reference 14
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.016939Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation dc24fdae-4342-4512-a53d-2ae1761aa3aa · outbound
This paper cites A consonance criterion for choosing sample size.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance A consonance criterion for choosing sample size
Reference 15
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:38.006158Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 6d488fa0-ec8e-46dc-a3a0-5cd4bbecee8e · outbound
This paper cites The role of the minimum clinically important difference and its impact on designing a trial.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance The role of the minimum clinically important difference and its impact on designing a trial
Reference 16
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.995099Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 974401c4-70aa-456c-9e64-58cfd5b82d80 · outbound
This paper cites A quantitative approach for making GO/NO-GO decisions in drug develop- ment.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance A quantitative approach for making GO/NO-GO decisions in drug develop- ment
Reference 17
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.983594Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 89fab669-0384-4b59-b20a-f566492f9f2d · outbound
This paper cites A proof of concept phase II non-inferiority criterion.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance A proof of concept phase II non-inferiority criterion
Reference 18
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.972439Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation b98d0029-ffcb-4e06-976c-0c865dca8faa · outbound
This paper cites Bayesian design of proof-of- concept trials.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Bayesian design of proof-of- concept trials
Reference 19
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.959657Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 944eb495-03cb-4972-bf6c-47714d998d82 · outbound
This paper cites Decision-making in early clinical drug development.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Decision-making in early clinical drug development
Reference 20
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.947281Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 117008b9-b18b-493d-83c3-33a9b5edde5f · outbound
This paper cites Statistical issues in drug development.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Statistical issues in drug development
Reference 21
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.934565Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation a69493e0-d736-4038-824d-0a68cebcd1e0 · outbound
This paper cites Reconciling Bayesian and frequentist evidence in the one-sided testing problem (C/R: P123-135).
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Reconciling Bayesian and frequentist evidence in the one-sided testing problem (C/R: P123-135)
Reference 22
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.924325Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation d9e39fca-644b-43e5-a0a8-8093bd2abec1 · outbound
This paper cites Testing a point null hypothesis: The irreconcilability of P values and evidence (C/R: P123-133, 135-139, 1201-1201).
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Testing a point null hypothesis: The irreconcilability of P values and evidence (C/R: P123-133, 135-139, 1201-1201)
Reference 23
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.912489Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation c24cf587-1233-44d7-91ae-b1f47e511a8c · outbound
This paper cites R: A Language and Environment for Statistical Computing.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance R: A Language and Environment for Statistical Computing
Reference 24
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.901190Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 878f4b82-343f-45a0-836e-5c4165a3e713 · outbound
This paper cites A practical guide to bayesian group sequential designs.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance A practical guide to bayesian group sequential designs
Reference 25
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.889876Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 1cb8d319-9adb-4918-a3f7-4392dc36e2b8 · outbound
This paper cites an unresolved cited work.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Unresolved cited work
Reference 26
- Resolution
- unresolved
- raw_fallback, observed 2026-08-14T12:16:37.877297Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 862a0b44-0562-4c10-9bbb-c3bb77ba8c10 · outbound
This paper cites an unresolved cited work.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Unresolved cited work
Reference 27
- Resolution
- unresolved
- raw_fallback, observed 2026-08-14T12:16:37.866896Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 924fd43c-f3bb-4387-abd4-9bfb92f65464 · outbound
This paper cites an unresolved cited work.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Unresolved cited work
Reference 28
- Resolution
- unresolved
- raw_fallback, observed 2026-08-14T12:16:37.854544Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 09be5e04-257d-4667-a303-bf03c5f11ecd · outbound
This paper cites an unresolved cited work.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Unresolved cited work
Reference 29
- Resolution
- unresolved
- raw_fallback, observed 2026-08-14T12:16:37.841187Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 4451bf1a-7eb4-48aa-956b-b6e72616d58b · outbound
This paper cites Example 2: operating characteristics for dual-criterion and three-outcome designs; probabilities for GO, NO-GO and inconclusive decisions given by the number of responders (r).
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Example 2: operating characteristics for dual-criterion and three-outcome designs; probabilities for GO, NO-GO and inconclusive decisions given by the number of responders (r)
Reference 30
- Resolution
- verified fuzzy
- raw_fallback, observed 2026-08-14T12:16:37.829014Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 0253ebe3-d98b-4a8d-a6fd-19ee923e12a0 · outbound
This paper cites an unresolved cited work.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Unresolved cited work
Reference 31
- Resolution
- unresolved
- raw_fallback, observed 2026-08-14T12:16:37.815325Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation 14323ec5-ceb2-445b-9658-0ad23392c55c · outbound
This paper cites an unresolved cited work.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Unresolved cited work
Reference 32
- Resolution
- unresolved
- raw_fallback, observed 2026-08-14T12:16:37.804053Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Observation f5a9331b-b173-4e30-9ece-82b9258a5548 · outbound
This paper cites an unresolved cited work.
Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance Unresolved cited work
Reference 33
- Resolution
- unresolved
- raw_fallback, observed 2026-08-14T12:16:37.792759Z
Source-reported events for the cited work
No event found in the named queried sources as of 2026-08-16T06:30:59.297886+00:00.
Pith citing papers
No inbound Pith citation observations are available.